Jun Qi
Affiliations: | Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States |
Google:
"Jun Qi"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| William R. Roush | grad student | 2001-2006 | University of Michigan |
| Mohammad Movassaghi | post-doc | 2006-2009 | MIT |
| James Bradner | research scientist | Dana-Farber Cancer Institute, Harvard Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Feng Y, Cai L, Pook M, et al. (2023) BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma. Biorxiv : the Preprint Server For Biology |
| Sevinç K, Sevinç GG, Cavga AD, et al. (2022) BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming. Stem Cell Reports |
| Guan X, Cheryala N, Karim RM, et al. (2022) Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity. Journal of Medicinal Chemistry |
| Ding J, Cui XG, Chen HJ, et al. (2022) Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma. Cancers. 14 |
| Zullow HJ, Sankar A, Ingram DR, et al. (2022) The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma. Molecular Cell |
| Wang MY, Liow P, Guzman MIT, et al. (2022) Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics. Acs Chemical Biology. 17: 744-755 |
| Zaiken MC, Flynn R, Paz KG, et al. (2022) BET-bromodomain and EZH2 inhibitor treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes. Blood |
| Yang Y, Li L, He H, et al. (2022) Numb inhibits migration and promotes proliferation of colon cancer cells via RhoA/ROCK signaling pathway repression. Experimental Cell Research. 411: 113004 |
| Durbin AD, Wang T, Wimalasena VK, et al. (2021) EP300 selectively controls the enhancer landscape of MYCN-amplified neuroblastoma. Cancer Discovery |
| Hideshima T, Mazitschek R, Qi J, et al. (2021) Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer. Oncotarget. 12: 1736 |